Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001387067 | SCV001587561 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2023-06-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1073925). This variant has not been reported in the literature in individuals affected with SGCB-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu28*) in the SGCB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCB are known to be pathogenic (PMID: 15938573, 18285821). |
Revvity Omics, |
RCV001387067 | SCV002020107 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001387067 | SCV004201019 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2E | 2021-11-13 | criteria provided, single submitter | clinical testing |